Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
BALANCE - MARCH 31, 2021 at Mar. 31, 2020 $ 9,368 $ 121,426,563 $ (112,026,381) $ (132,124) $ 9,277,426
Beginning balance, shares at Mar. 31, 2020 9,366,873        
Issuances of common stock for cash under at the market program $ 2,686 7,258,183 7,260,869
Issuances of common stock for cash under at the market program, shares 2,685,600        
Issuance of common shares upon vesting of restricted stock units and net stock option exercise $ 98 (132,625) (132,527)
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares 98,124        
Stock-based compensation expense 779,421 779,421
Net loss (7,886,709) (4,790) (7,891,499)
BALANCE - MARCH 31, 2022 at Mar. 31, 2021 $ 12,152 129,331,542 (119,913,090) (136,914) 9,293,690
Ending balance, shares at Mar. 31, 2021 12,150,597        
Issuances of common stock for cash under at the market program $ 626 4,947,159 4,947,785
Issuances of common stock for cash under at the market program, shares 626,000        
Issuances of common stock for cash in registered direct financing $ 1,381 11,657,663 11,659,044
Issuances of common stock for cash in registered direct financing, shares 1,380,555        
Issuances of common stock for cash under warrant exercises $ 531 820,407 820,938
Issuances of common stock for cash under warrant exercises, shares 531,167        
Issuances of common stock for cash under stock option exercises $ 11 28,314 28,325
Issuances of common stock for cash under stock option exercises, shares 11,562        
Issuances of common stock under cashless warrant exercises $ 676 (676)
Issuances of common stock under cashless warrant exercises, shares 675,554        
Issuance of common shares upon vesting of restricted stock units and net stock option exercise $ 44 (88,162) (88,118)
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares 43,728        
Stock-based compensation expense 750,621 750,621
Net loss (10,416,091) (4,794) (10,420,885)
BALANCE - MARCH 31, 2022 at Mar. 31, 2022 $ 15,421 $ 147,446,868 $ (130,329,181) $ (141,708) $ 16,991,400
Ending balance, shares at Mar. 31, 2022 15,419,163